var data={"title":"Benign skin and scalp lesions in the newborn and infant","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Benign skin and scalp lesions in the newborn and infant</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/contributors\" class=\"contributor contributor_credentials\">Josie A Pielop, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/contributors\" class=\"contributor contributor_credentials\">Moise L Levy, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/contributors\" class=\"contributor contributor_credentials\">Leonard E Weisman, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/contributors\" class=\"contributor contributor_credentials\">Rosamaria Corona, MD, DSc</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Jul 31, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Benign skin lesions in the newborn are reviewed here. Blistering conditions in the newborn caused by infection, congenital abnormalities, infiltrative disease, vascular lesions, and congenital nevi are discussed separately. (See <a href=\"topic.htm?path=vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant\" class=\"medical medical_review\">&quot;Vesiculopustular and bullous lesions in the newborn and infant&quot;</a> and <a href=\"topic.htm?path=skin-nodules-in-newborns-and-infants\" class=\"medical medical_review\">&quot;Skin nodules in newborns and infants&quot;</a> and <a href=\"topic.htm?path=vascular-lesions-in-the-newborn\" class=\"medical medical_review\">&quot;Vascular lesions in the newborn&quot;</a> and <a href=\"topic.htm?path=congenital-melanocytic-nevi\" class=\"medical medical_review\">&quot;Congenital melanocytic nevi&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">SKIN LESIONS</span></p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h2\">Benign vesiculopustular lesions</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Although most vesiculopustular eruptions in newborns are benign and self-limiting, the differential diagnosis includes conditions that require prompt recognition <span class=\"nowrap\">and/or</span> therapy (<a href=\"image.htm?imageKey=PEDS%2F75417\" class=\"graphic graphic_table graphicRef75417 \">table 1</a>). (See <a href=\"topic.htm?path=vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant\" class=\"medical medical_review\">&quot;Vesiculopustular and bullous lesions in the newborn and infant&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h3\">Erythema toxicum neonatorum</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Erythema toxicum neonatorum (ETN) occurs in 31 to 72 percent of full-term infants but declines in incidence with decreasing birth weight and gestational age [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/1\" class=\"abstract_t\">1</a>]. The etiology is not known, but immaturity of the pilosebaceous follicles (the combined sebaceous gland and hair follicle) may contribute [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/2\" class=\"abstract_t\">2</a>].</p><p>ETN is characterized by multiple erythematous macules and papules (1 to 3 mm in diameter) that rapidly progress to pustules on an erythematous base (<a href=\"image.htm?imageKey=DERM%2F70785%7EDERM%2F78577\" class=\"graphic graphic_picture graphicRef70785 graphicRef78577 \">picture 1A-B</a>)&nbsp;[<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/3\" class=\"abstract_t\">3</a>]. The lesions are distributed over the trunk and proximal extremities, sparing the palms and soles. They may be present at birth, but typically appear within 24 to 48 hours. The rash usually resolves in five to seven days, although it may wax and wane before complete resolution [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/1\" class=\"abstract_t\">1</a>].</p><p>The diagnosis of ETN is usually made upon the basis of clinical appearance. It can be confirmed by microscopic examination of a Wright-stained smear of the contents of a pustule that demonstrates numerous eosinophils and occasional neutrophils. However, this usually is not necessary. A minority of patients (7 to 18 percent) may also have peripheral eosinophilia [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/4\" class=\"abstract_t\">4</a>].</p><p>If the presentation is atypical, cultures of the pustule contents for bacteria, fungus, and virus should be obtained (<a href=\"image.htm?imageKey=PEDS%2F75417\" class=\"graphic graphic_table graphicRef75417 \">table 1</a>); these are all negative in ETN. (See <a href=\"topic.htm?path=vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant\" class=\"medical medical_review\">&quot;Vesiculopustular and bullous lesions in the newborn and infant&quot;</a>.)</p><p>ETN resolves spontaneously. No treatment is necessary.</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h3\">Transient neonatal pustular melanosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Transient neonatal pustular melanosis (TNPM) is less common than ETN. It mostly affects full-term black infants, although it is described in all races [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/5\" class=\"abstract_t\">5</a>].</p><p>TNPM consists of three types of lesions [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/6\" class=\"abstract_t\">6</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Small pustules on a nonerythematous base; these usually are present at birth</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Erythematous macules with a surrounding collarette of scale (<a href=\"image.htm?imageKey=DERM%2F64567\" class=\"graphic graphic_picture graphicRef64567 \">picture 2</a>); these develop as the pustules rupture and may persist for weeks to months</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hyperpigmented macules that gradually fade over several weeks to months (<a href=\"image.htm?imageKey=PEDS%2F59397\" class=\"graphic graphic_picture graphicRef59397 \">picture 3</a>)</p><p/><p>Lesions in different stages may be present at the same time, even at birth [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/6\" class=\"abstract_t\">6</a>].</p><p>The diagnosis of TNPM is usually based upon the clinical appearance. Microscopic examination of a Wright-stained smear of the contents of a pustule demonstrates numerous neutrophils and rare eosinophils (in contrast to ETN). However, this is usually not necessary. Culture, if performed, yields no organism. No treatment is necessary.</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h3\">Neonatal acne</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Neonatal acne occurs in approximately 20 percent of infants and does not appear to run in families [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/7\" class=\"abstract_t\">7</a>]. Once thought to be caused by stimulation of sebaceous glands by maternal and endogenous androgens, many authors doubt that it is true acne and now call it neonatal cephalic pustulosis [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/8\" class=\"abstract_t\">8</a>]. An inflammatory reaction to skin colonization with Malassezia species has been proposed, especially in severe cases [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/9,10\" class=\"abstract_t\">9,10</a>], although one series found no correlation between disease severity and lesional Malassezia culture positivity or nonlesional skin colonization [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/11\" class=\"abstract_t\">11</a>].</p><p>The mean age at onset is three weeks [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/7\" class=\"abstract_t\">7</a>]. The presence of inflammatory papules and pustules, the absence of comedonal lesions, and the characteristic distribution limited to the face (especially the cheeks), and sometimes the scalp, are diagnostic in most cases (<a href=\"image.htm?imageKey=DERM%2F56615\" class=\"graphic graphic_picture graphicRef56615 \">picture 4</a>). Neonatal cephalic pustulosis may appear very similar to miliaria rubra. (See <a href=\"#H10\" class=\"local\">'Miliaria'</a> below.)</p><p>In the majority of cases, neonatal cephalic pustulosis is mild and can be treated with daily cleansing with soap and water and avoidance of exogenous oils and lotions [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/12\" class=\"abstract_t\">12</a>]. No additional treatment is needed since neonatal cephalic pustulosis usually resolves spontaneously within four months without scarring [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/12\" class=\"abstract_t\">12</a>]. Application of 2% <a href=\"topic.htm?path=ketoconazole-drug-information\" class=\"drug drug_general\">ketoconazole</a> cream twice daily [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/13\" class=\"abstract_t\">13</a>] or 1% <a href=\"topic.htm?path=hydrocortisone-drug-information\" class=\"drug drug_general\">hydrocortisone</a> cream once daily may expedite clearance of lesions. Affected newborns do not appear to have a greater risk of acne in adolescence.</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h3\">Infantile acne</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Infantile acne is a distinct entity from neonatal cephalic pustulosis. It presents at three to four months of age. It results from hyperplasia of sebaceous glands secondary to androgenic stimulation, and is more common in boys [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/14\" class=\"abstract_t\">14</a>]. The clinical presentation is more severe than that of cephalic pustulosis and consists of typical acneiform lesions including comedones, inflammatory papules, pustules, and sometimes nodules on the face [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/8\" class=\"abstract_t\">8</a>]. It usually clears spontaneously by late in the first year of life, but may persist until three years of age.</p><p>Treatment may be required, because infantile acne can persist and occasionally cause scarring, unlike neonatal cephalic pustulosis. When inflammation is mild or moderate, mild keratolytic agents, such as <a href=\"topic.htm?path=benzoyl-peroxide-drug-information\" class=\"drug drug_general\">benzoyl peroxide</a> (2.5%), topical antibiotics (eg, <a href=\"topic.htm?path=erythromycin-drug-information\" class=\"drug drug_general\">erythromycin</a> or <a href=\"topic.htm?path=clindamycin-drug-information\" class=\"drug drug_general\">clindamycin</a>), or topical retinoids may be used [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/15\" class=\"abstract_t\">15</a>]. In more severe cases, systemic therapy with oral erythromycin or oral <a href=\"topic.htm?path=isotretinoin-drug-information\" class=\"drug drug_general\">isotretinoin</a> may be indicated [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/15,16\" class=\"abstract_t\">15,16</a>].</p><p>Parents should be instructed to test for local reaction to topical therapies by applying a small amount to the antecubital fossa before widespread use or application to the face [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/17\" class=\"abstract_t\">17</a>]. Topical therapies should initially be applied every other night and increased to every night as tolerated unless otherwise indicated.</p><p>Severe, unremitting infantile acne may warrant evaluation for underlying androgen excess due to congenital adrenal hyperplasia, a gonadal or adrenal tumor, or precocious puberty [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/8\" class=\"abstract_t\">8</a>]. Some patients have recurrence of severe acne at puberty.</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h3\">Infantile acropustulosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Infantile acropustulosis (IA) is a benign vesiculopustular condition with an often more chronic course than other benign neonatal lesions. The etiology is unknown. A nonspecific hypersensitivity reaction to scabies has been postulated because many patients have been treated for scabies before being diagnosed with IA [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/18,19\" class=\"abstract_t\">18,19</a>]. However, the diagnosis of scabies in these patients was rarely verified microscopically [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/19\" class=\"abstract_t\">19</a>]. One survey suggested that IA is common in internationally adopted children, many of whom had been diagnosed with scabies after living in crowded living conditions early in life [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/20\" class=\"abstract_t\">20</a>].</p><p>Some suggest that black male infants are more commonly affected [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/21\" class=\"abstract_t\">21</a>], but others found no gender or racial predisposition [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/22\" class=\"abstract_t\">22</a>]. A family history may be informative because siblings are sometimes affected [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/22\" class=\"abstract_t\">22</a>].</p><p>IA is characterized by recurrent crops of intensely pruritic vesiculopustules, mainly on the palms and soles, but sometimes involving the limbs (<a href=\"image.htm?imageKey=DERM%2F77411%7EDERM%2F55499\" class=\"graphic graphic_picture graphicRef77411 graphicRef55499 \">picture 5A-B</a>). It may be present at birth or have onset any time during the first year of life. Recurrences generally occur every two to four weeks and may last 5 to 10 days. Infants are often fussy during these flares.</p><p>The differential diagnosis of IA includes dyshidrotic eczema, pustular psoriasis, ETN, TNPM, scabies, and impetigo [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/3\" class=\"abstract_t\">3</a>]. (See <a href=\"topic.htm?path=acute-palmoplantar-eczema-dyshidrotic-eczema\" class=\"medical medical_review\">&quot;Acute palmoplantar eczema (dyshidrotic eczema)&quot;</a> and <a href=\"topic.htm?path=pustular-psoriasis-pathogenesis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Pustular psoriasis: Pathogenesis, clinical manifestations, and diagnosis&quot;</a> and <a href=\"#H4\" class=\"local\">'Erythema toxicum neonatorum'</a> above and <a href=\"#H5\" class=\"local\">'Transient neonatal pustular melanosis'</a> above.)</p><p>The diagnosis of IA is based upon clinical features. Because of the association with scabies, skin scrapings should be examined [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/19,23\" class=\"abstract_t\">19,23</a>]. Skin biopsy usually is not necessary, but if performed, demonstrates a subcorneal pustule filled with neutrophils and eosinophils [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/24\" class=\"abstract_t\">24</a>].</p><p>IA typically resolves within two years. Therapy for IA has not been studied in randomized trials, and the optimal treatment is controversial. Treatment with topical corticosteroids, oral antihistamines, oral <a href=\"topic.htm?path=erythromycin-drug-information\" class=\"drug drug_general\">erythromycin</a>, and oral <a href=\"topic.htm?path=dapsone-drug-information\" class=\"drug drug_general\">dapsone</a> have been beneficial in case reports or case series, although the findings are inconsistent except for dapsone [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/19,22,24-27\" class=\"abstract_t\">19,22,24-27</a>]. Although dapsone is reliably effective, it has potentially serious adverse effects [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/19\" class=\"abstract_t\">19</a>].</p><p>In the largest series of IA patients, 20 of 21 were treated with high- to mid-potency topical corticosteroids (Group 1 to 4, (<a href=\"image.htm?imageKey=DERM%2F62402\" class=\"graphic graphic_table graphicRef62402 \">table 2</a>)) once or twice per day [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/19\" class=\"abstract_t\">19</a>]. The 18 who returned for follow-up had improvement (decrease in the number of lesions, frequency of recurrence, and pruritus) or marked improvement (complete resolution with no recurrence). Improvement was noted between three days and two weeks after initiation of therapy. No cutaneous or systemic complications were recorded.</p><p>We suggest mid- to high-potency topical corticosteroids (Group 1 to 4, (<a href=\"image.htm?imageKey=DERM%2F62402\" class=\"graphic graphic_table graphicRef62402 \">table 2</a>)) as the first-line treatment for flares of IA [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/19,22\" class=\"abstract_t\">19,22</a>]. Systemic absorption of topical corticosteroids in IA is limited by the localized distribution of the lesions, the thickness of skin in the affected (acral) areas, and the periodicity of the flares [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/3,19\" class=\"abstract_t\">3,19</a>]. (See <a href=\"topic.htm?path=general-principles-of-dermatologic-therapy-and-topical-corticosteroid-use#H14\" class=\"medical medical_review\">&quot;General principles of dermatologic therapy and topical corticosteroid use&quot;, section on 'Use in children'</a>.)</p><p><a href=\"topic.htm?path=erythromycin-drug-information\" class=\"drug drug_general\">Erythromycin</a> (40 <span class=\"nowrap\">mg/kg</span> per day by mouth) or oral antihistamines are alternatives to topical corticosteroids. Erythromycin appears to have an antiinflammatory effect. Antihistamines are effective in relieving pruritus, but only in high doses, suggesting that sedation is necessary for efficacy [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/19,26\" class=\"abstract_t\">19,26</a>].</p><p>We suggest that <a href=\"topic.htm?path=dapsone-drug-information\" class=\"drug drug_general\">dapsone</a> (1 to 2 <span class=\"nowrap\">mg/kg</span> per day by mouth) be reserved for severe, recalcitrant cases [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/19\" class=\"abstract_t\">19</a>]. Adverse effects of dapsone may include peripheral neuropathy, aplastic anemia, hepatitis, hemolytic anemia, and methemoglobinemia [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/19\" class=\"abstract_t\">19</a>]. A G6PD screen should be done before starting dapsone. (See <a href=\"topic.htm?path=diagnosis-and-management-of-glucose-6-phosphate-dehydrogenase-deficiency\" class=\"medical medical_review\">&quot;Diagnosis and management of glucose-6-phosphate dehydrogenase deficiency&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h3\">Milia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Milia are white papules caused by retention of keratin and sebaceous material in the pilaceous follicles. They are frequently found on the nose and cheeks, and resolve in the first few weeks of life.</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h3\">Miliaria</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Miliaria is a common finding in newborns, especially in warm climates. It is caused by accumulation of sweat beneath eccrine sweat ducts that are obstructed by keratin at the level of the stratum corneum. (See <a href=\"topic.htm?path=miliaria\" class=\"medical medical_review\">&quot;Miliaria&quot;</a>.)</p><p>Several types of lesions may result [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/14,17,28\" class=\"abstract_t\">14,17,28</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Miliaria crystallina is characterized by small thin-walled vesicles resembling dewdrops without inflammation (<a href=\"image.htm?imageKey=PEDS%2F55627\" class=\"graphic graphic_picture graphicRef55627 \">picture 6</a>).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Miliaria rubra (&quot;heat rash,&quot; &quot;prickly heat&quot;) occurs when the obstructed sweat leaks into the dermis and causes a localized inflammatory response, resulting in small groups of erythematous papules and pustules (<a href=\"image.htm?imageKey=PEDS%2F68376\" class=\"graphic graphic_picture graphicRef68376 \">picture 7</a>).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Miliaria pustulosa also results from localized inflammation; it consists of pustules with an erythematous base similar to miliaria rubra.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Miliaria profunda is papular or papulopustular and skin colored.</p><p/><p>Miliaria rarely is present at birth. It usually develops during the first week of life, especially in association with warming of the infant by an incubator, occlusive dressings or clothing, or fever. It is characteristically distributed on the face, scalp, and intertriginous areas.</p><p>The diagnosis of miliaria is based upon the clinical features. Microscopic examination of a Wright-stained smear of the contents of a vesicular lesion demonstrates sparse squamous cells and lymphocytes. However, this is usually not necessary.</p><p>No specific treatment is needed. Lesions usually resolve rapidly when the infant is placed in a cooler environment with associated measures to reduce sweating, such as light, loose clothing and cool baths. </p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h3\">Sucking blisters</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Congenital sucking blisters, a diagnosis of exclusion, are noninflammatory oval, thick-walled vesicles or bullae that contain sterile fluid [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/29\" class=\"abstract_t\">29</a>]. The lesions may be unilateral or bilateral and typically are located on the dorsal or radial aspect of the wrists, hands, or fingers of neonates who are noted to suck excessively at the involved regions (<a href=\"image.htm?imageKey=PEDS%2F78479\" class=\"graphic graphic_picture graphicRef78479 \">picture 8</a>).</p><p>The differential diagnosis of sucking blisters includes herpes simplex virus infection, bullous impetigo, congenital syphilis or candidiasis, neonatal lupus erythematosus, and hereditary bullous diseases [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/29\" class=\"abstract_t\">29</a>]. These disorders are usually, but not always, accompanied by additional clinical signs or suggestive maternal history. (See <a href=\"topic.htm?path=vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant\" class=\"medical medical_review\">&quot;Vesiculopustular and bullous lesions in the newborn and infant&quot;</a>.)</p><p>Observation of the neonate's sucking on the involved areas is the most helpful clue to the correct diagnosis of congenital sucking blisters. Other suggestive features include the absence of lesions in other areas, well-appearance of the infant, and rapid resolution of the lesions.</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h2\">Vascular birthmarks</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Vascular birthmarks include vascular tumors and vascular malformations. Many are clinically insignificant, but others have associated abnormalities or develop complications. These lesions are discussed separately.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=vascular-lesions-in-the-newborn\" class=\"medical medical_review\">&quot;Vascular lesions in the newborn&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=infantile-hemangiomas-epidemiology-pathogenesis-clinical-features-and-complications\" class=\"medical medical_review\">&quot;Infantile hemangiomas: Epidemiology, pathogenesis, clinical features, and complications&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=rapidly-involuting-congenital-hemangioma-rich-and-noninvoluting-congenital-hemangioma-nich\" class=\"medical medical_review\">&quot;Rapidly involuting congenital hemangioma (RICH) and noninvoluting congenital hemangioma (NICH)&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=tufted-angioma-kaposiform-hemangioendothelioma-and-the-kasabach-merritt-phenomenon\" class=\"medical medical_review\">&quot;Tufted angioma, kaposiform hemangioendothelioma, and the Kasabach-Merritt phenomenon&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=sturge-weber-syndrome\" class=\"medical medical_review\">&quot;Sturge-Weber syndrome&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=klippel-trenaunay-syndrome-clinical-manifestations-diagnosis-and-management\" class=\"medical medical_review\">&quot;Klippel-Trenaunay syndrome: Clinical manifestations, diagnosis, and management&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H13\"><span class=\"h2\">Color changes</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Benign causes of color changes in neonates include physiologic changes and vascular and melanocytic lesions.</p><p class=\"headingAnchor\" id=\"H14\"><span class=\"h3\">Cutis marmorata</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Cutis marmorata is characterized by symmetric, reticular mottling of the skin of the extremities and trunk (<a href=\"image.htm?imageKey=PEDS%2F53396%7EDERM%2F50846\" class=\"graphic graphic_picture graphicRef53396 graphicRef50846 \">picture 9A-B</a>)&nbsp;[<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/17\" class=\"abstract_t\">17</a>]. It is caused by a vascular response to cold and usually resolves with warming. No treatment is required.</p><p>Physiologic cutis marmorata must be distinguished from cutis marmorata telangiectatica congenita, a vascular malformation in which the lesions do not resolve with warming [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/30\" class=\"abstract_t\">30</a>]. Cutis marmorata telangiectatica congenita may be associated with extracutaneous findings. (See <a href=\"topic.htm?path=vascular-lesions-in-the-newborn#H8\" class=\"medical medical_review\">&quot;Vascular lesions in the newborn&quot;, section on 'Cutis marmorata telangiectatica congenita'</a>.)</p><p class=\"headingAnchor\" id=\"H15\"><span class=\"h3\">Harlequin color change</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Harlequin color change is observed when an infant is lying on his or her side. It is characterized by intense reddening of the dependent side and blanching of the non-dependent side, with a demarcation line along the midline. The duration ranges from a few seconds to 20 minutes. The etiology of harlequin color change is unknown. It may be related to immaturity of the autonomic regulation of cutaneous blood vessel tone [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/14\" class=\"abstract_t\">14</a>].</p><p>Harlequin color change affects approximately 10 percent of newborns, occurring more often in preterm than term infants. The frequency is greatest in the first few days of life, but it has been observed up to three weeks after birth.</p><p>Harlequin color change is entirely benign. It should not be confused with the harlequin fetus, the most severe form of congenital ichthyosis that is lethal in the neonatal period. (See <a href=\"topic.htm?path=the-genodermatoses#H3\" class=\"medical medical_review\">&quot;The genodermatoses&quot;, section on 'Ichthyoses'</a>.)</p><p class=\"headingAnchor\" id=\"H16\"><span class=\"h3\">Congenital dermal melanocytosis (Mongolian spot)</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Congenital dermal melanocytosis, also called Mongolian spot, is the most frequently encountered pigmented lesion in newborns. There are marked ethnic differences in prevalence [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/31-34\" class=\"abstract_t\">31-34</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>85 to 100 percent in Asian neonates</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>&gt;60 percent in black neonates</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>46 to 70 percent in Hispanic neonates</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>&lt;10 percent in white neonates</p><p/><p>Congenital dermal melanocytosis typically appears as a blue-grey pigmented macule with indefinite borders, although it also can be greenish-blue or brown (<a href=\"image.htm?imageKey=PEDS%2F77805\" class=\"graphic graphic_picture graphicRef77805 \">picture 10</a>). The diameter of the lesion may be 10 cm or more. The most common location is the sacral-gluteal region, followed by the shoulders [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/31\" class=\"abstract_t\">31</a>]. They rarely occur on the head, face, or flexor surface of the extremities.</p><p>Congenital dermal melanocytosis is completely benign and usually fades during the first or second year of life [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/35\" class=\"abstract_t\">35</a>]. By 6 to 10 years of age, the vast majority has disappeared. However, approximately 3 percent remain into adulthood, particularly those in extrasacral locations.</p><p>The lesions result from the delayed disappearance of dermal melanocytes. The sacral area and medial buttocks are sites where active dermal melanocytes frequently remain at birth. Dermal melanocytosis is less often seen in extrasacral (&quot;aberrant&quot;) sites (eg, the superior or anterior trunk and extremities). A biopsy, which is rarely indicated, shows the widely spaced dermal melanocytes in the deep dermis.</p><p>Although the distinctive clinical appearance of ill-defined, homogeneous gray-blue patches is usually diagnostic, particularly when located in classic sites, there are reports of false accusations of child abuse resulting from misinterpretation of congenital dermal melanocytosis as bruises (which tend to change color and resolve more quickly) [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/31\" class=\"abstract_t\">31</a>]. (See <a href=\"topic.htm?path=differential-diagnosis-of-suspected-child-physical-abuse#H2\" class=\"medical medical_review\">&quot;Differential diagnosis of suspected child physical abuse&quot;, section on 'Bruises'</a>.)</p><p>Congenital dermal melanocytosis should be distinguished from other lesions that do not fade, such as blue nevi, nevus of Ota, or nevus of Ito. Blue nevi are rare in children, appear mainly on the scalp, face, dorsa of hands and feet, and have a raised irregular surface with more discrete borders. Nevus of Ota and nevus of Ito have a specific distribution, occurring in the <span class=\"nowrap\">V1/V2</span> dermatomes of the face and on the neck and shoulders, respectively. Blue nevi [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/36\" class=\"abstract_t\">36</a>] and nevus of Ota [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/37\" class=\"abstract_t\">37</a>] are rarely associated with malignant changes, whereas Mongolian spots are completely benign. (See <a href=\"topic.htm?path=acquired-melanocytic-nevi-moles#H21\" class=\"medical medical_review\">&quot;Acquired melanocytic nevi (moles)&quot;, section on 'Blue nevi'</a> and <a href=\"topic.htm?path=benign-pigmented-skin-lesions-other-than-melanocytic-nevi-moles#H16\" class=\"medical medical_review\">&quot;Benign pigmented skin lesions other than melanocytic nevi (moles)&quot;, section on 'Nevus of Ota'</a> and <a href=\"topic.htm?path=benign-pigmented-skin-lesions-other-than-melanocytic-nevi-moles#H18\" class=\"medical medical_review\">&quot;Benign pigmented skin lesions other than melanocytic nevi (moles)&quot;, section on 'Nevus of Ito'</a>.)</p><p>Although there are no reports of malignant degeneration, Mongolian spots and other types of dermal melanocytosis have been associated with a number of pediatric disorders, as illustrated below.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Extensive dermal melanocytosis with a ventral as well as dorsal distribution that is persistent <span class=\"nowrap\">and/or</span> progressive in nature has been reported in at least 40 children with various lysosomal storage diseases [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/38-40\" class=\"abstract_t\">38-40</a>]. (See <a href=\"topic.htm?path=inborn-errors-of-metabolism-classification#H11\" class=\"medical medical_review\">&quot;Inborn errors of metabolism: Classification&quot;, section on 'Lysosomal storage disorders'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Clinically apparent dermal pigmentation of the perioral area has been described in up to 20 to 50 percent of patients with cleft lip, implying a common pathogenic defect in migration of cells from the neural crest [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/41\" class=\"abstract_t\">41</a>].</p><p/><p>In phakomatosis pigmentovascularis type II, aberrant Mongolian spots are seen in association with capillary malformations (port-wine stains); patients are further categorized based on the presence or absence of associated systemic features (eg, Sturge-Weber syndrome or glaucoma). (See <a href=\"topic.htm?path=vascular-lesions-in-the-newborn#H9\" class=\"medical medical_review\">&quot;Vascular lesions in the newborn&quot;, section on 'Phakomatosis pigmentovascularis'</a> and <a href=\"topic.htm?path=capillary-malformations-port-wine-stains-and-associated-syndromes\" class=\"medical medical_review\">&quot;Capillary malformations (port wine stains) and associated syndromes&quot;</a>.)</p><p>Congenital dermal melanocytosis usually resolves spontaneously during the first decade of life. It is prudent to document these lesions at least upon initial physical examination; this will help to avoid confusion with bruises in the event that child abuse is suspected. (See <a href=\"topic.htm?path=differential-diagnosis-of-suspected-child-physical-abuse#H2\" class=\"medical medical_review\">&quot;Differential diagnosis of suspected child physical abuse&quot;, section on 'Bruises'</a>.)</p><p class=\"headingAnchor\" id=\"H17\"><span class=\"h3\">Bronze baby syndrome</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Bronze baby syndrome refers to the diffuse gray-brown discoloration of the skin that may develop in infants one to seven days after initiation of phototherapy for hyperbilirubinemia. The serum and urine also become bronze. The condition gradually resolves without sequelae within several weeks after discontinuation of therapy. (See <a href=\"topic.htm?path=treatment-of-unconjugated-hyperbilirubinemia-in-term-and-late-preterm-infants\" class=\"medical medical_review\">&quot;Treatment of unconjugated hyperbilirubinemia in term and late preterm infants&quot;</a>.)</p><p>The bronze color is thought to result from cholestasis and impaired biliary excretion of bile pigment photoproducts, including copper porphyrins, which are brown [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/42,43\" class=\"abstract_t\">42,43</a>]. Most affected babies have direct hyperbilirubinemia and retention of bile acids before phototherapy or after developing the syndrome. To avoid bronze baby syndrome, phototherapy generally should not be used in infants with direct hyperbilirubinemia or other manifestations of cholestasis.</p><p class=\"headingAnchor\" id=\"H18\"><span class=\"h1\">SCALP LESIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Benign scalp lesions in newborns and young infants include seborrheic dermatitis (&quot;cradle cap&quot;), nevus sebaceous of Jadassohn, halo scalp ring, and caput succedaneum.</p><p class=\"headingAnchor\" id=\"H19\"><span class=\"h2\">Seborrheic dermatitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Seborrheic dermatitis is characterized by erythema and greasy scales. It occurs most commonly on the scalp, but also on the face, ears, neck, and in the diaper area (<a href=\"image.htm?imageKey=PEDS%2F55801\" class=\"graphic graphic_picture graphicRef55801 \">picture 11</a>). Seborrheic dermatitis in infants is discussed separately. (See <a href=\"topic.htm?path=cradle-cap-and-seborrheic-dermatitis-in-infants\" class=\"medical medical_review\">&quot;Cradle cap and seborrheic dermatitis in infants&quot;</a>.) </p><p class=\"headingAnchor\" id=\"H20\"><span class=\"h2\">Nevus sebaceous of Jadassohn</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Nevus sebaceous of Jadassohn is a congenital lesion that occurs primarily on the scalp or face (<a href=\"image.htm?imageKey=DERM%2F89876%7EDERM%2F89878\" class=\"graphic graphic_picture graphicRef89876 graphicRef89878 \">picture 12A-B</a>). It is a hamartoma that combines epidermal, follicular, sebaceous, and apocrine gland abnormalities [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/44\" class=\"abstract_t\">44</a>]. Nevus sebaceous and nevus sebaceous syndrome are discussed separately. (See <a href=\"topic.htm?path=nevus-sebaceus-and-nevus-sebaceus-syndrome\" class=\"medical medical_review\">&quot;Nevus sebaceus and nevus sebaceus syndrome&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H21\"><span class=\"h2\">Aplasia cutis congenita</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Aplasia cutis congenita is a group of heterogeneous diseases characterized by congenital focal absence of the skin. It is most often limited to a solitary midline posterior scalp lesion. Aplasia cutis is discussed separately. (See <a href=\"topic.htm?path=vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant#H19\" class=\"medical medical_review\">&quot;Vesiculopustular and bullous lesions in the newborn and infant&quot;, section on 'Aplasia cutis congenita'</a>.)</p><p class=\"headingAnchor\" id=\"H3861904392\"><span class=\"h2\">Caput succedaneum</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Caput succedaneum is an edematous swelling of the scalp above the periosteum that presents at birth after prolonged engagement of the fetal head in the birth canal or after vacuum extraction. Complications include halo scalp ring and erosive and necrotic lesions resulting in long-term scarring and alopecia. (See <a href=\"topic.htm?path=neonatal-birth-injuries#H7\" class=\"medical medical_review\">&quot;Neonatal birth injuries&quot;, section on 'Extracranial injuries'</a>.)</p><p class=\"headingAnchor\" id=\"H22\"><span class=\"h3\">Halo scalp ring</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Halo scalp ring is a ring-shaped area of alopecia that develops in some infants with caput succedaneum [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/45\" class=\"abstract_t\">45</a>]. The alopecia usually resolves over a period of months to years, but may be permanent [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/45,46\" class=\"abstract_t\">45,46</a>]. </p><p class=\"headingAnchor\" id=\"H23\"><span class=\"h2\">Erosive pustular dermatosis of the scalp</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In infants with perinatal scalp injury, hair loss may be accompanied by pustular, erosive, and crusted lesions unresponsive to topical or oral antibiotics (erosive pustular dermatosis of the scalp [EPDS]) [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/47\" class=\"abstract_t\">47</a>]. EPDS may respond to treatment with topical corticosteroids, minimizing the risk of permanent hair loss.</p><p class=\"headingAnchor\" id=\"H2244910472\"><span class=\"h2\">Benign cephalic histiocytosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Benign cephalic histiocytosis (BCH), also called papular histiocytosis of the head, is a rare, self-healing type of non-Langerhans cell histiocytosis that typically occurs in infants and young children, with an average age of onset of 15 months [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/48,49\" class=\"abstract_t\">48,49</a>]. BCH presents with small, yellow-red or yellow-brown, asymptomatic macules <span class=\"nowrap\">and/or</span> papules located mostly on the head and neck (<a href=\"image.htm?imageKey=DERM%2F113955%7EDERM%2F113956\" class=\"graphic graphic_picture graphicRef113955 graphicRef113956 \">picture 13A-B</a>). In some cases, lesions may extend to involve the trunk and upper and lower extremities. There is no visceral involvement.</p><p>The diagnosis is in most cases clinical. However, if the diagnosis is in doubt, a skin biopsy for histology and immunostaining should be performed. The histopathologic hallmark of BCH is a well-circumscribed histiocytic infiltrate in the superficial and reticular dermis [<a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/49\" class=\"abstract_t\">49</a>]. Immunohistochemical staining of lesional cells demonstrates positive staining for factor XIIIa, fascin, and CD68 but negative for CD1a, langerin, and S100 (<a href=\"image.htm?imageKey=DERM%2F59870\" class=\"graphic graphic_table graphicRef59870 \">table 3</a>).</p><p>The differential diagnosis may include multiple Spitz nevi, juvenile xanthogranuloma, Langerhans cell histiocytosis, urticaria pigmentosa, and generalized eruptive histiocytosis. (See <a href=\"topic.htm?path=spitzoid-melanocytic-neoplasms-spitz-nevus-and-atypical-spitz-tumors\" class=\"medical medical_review\">&quot;Spitzoid melanocytic neoplasms (Spitz nevus and atypical Spitz tumors)&quot;</a> and <a href=\"topic.htm?path=juvenile-xanthogranuloma-jxg\" class=\"medical medical_review\">&quot;Juvenile xanthogranuloma (JXG)&quot;</a> and <a href=\"topic.htm?path=clinical-manifestations-pathologic-features-and-diagnosis-of-langerhans-cell-histiocytosis\" class=\"medical medical_review\">&quot;Clinical manifestations, pathologic features, and diagnosis of Langerhans cell histiocytosis&quot;</a> and <a href=\"topic.htm?path=mastocytosis-cutaneous-and-systemic-evaluation-and-diagnosis-in-children\" class=\"medical medical_review\">&quot;Mastocytosis (cutaneous and systemic): Evaluation and diagnosis in children&quot;</a>.)</p><p>Given the self-limiting nature of BCH, no treatment is needed. Lesions regress spontaneously over several months to years. Some resolve with superficial epidermal atrophy. </p><p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\"><span class=\"h1\">INFORMATION FOR PATIENTS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>UpToDate offers two types of patient education materials, &quot;The Basics&quot; and &quot;Beyond the Basics.&quot; The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &quot;patient info&quot; and the keyword(s) of interest.) </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Basics topic (see <a href=\"topic.htm?path=heat-rash-prickly-heat-the-basics\" class=\"medical medical_basics\">&quot;Patient education: Heat rash (prickly heat) (The Basics)&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Beyond the Basics topics (see <a href=\"topic.htm?path=seborrheic-dermatitis-including-dandruff-and-cradle-cap-beyond-the-basics\" class=\"medical medical_patient\">&quot;Patient education: Seborrheic dermatitis (including dandruff and cradle cap) (Beyond the Basics)&quot;</a> and <a href=\"topic.htm?path=atopic-dermatitis-eczema-beyond-the-basics\" class=\"medical medical_patient\">&quot;Patient education: Atopic dermatitis (eczema) (Beyond the Basics)&quot;</a>)</p><p/><p class=\"headingAnchor\" id=\"H25\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Although most vesiculopustular eruptions in newborns and infants are benign and self-limiting, the differential diagnosis includes conditions that require prompt recognition <span class=\"nowrap\">and/or</span> therapy (<a href=\"image.htm?imageKey=PEDS%2F75417\" class=\"graphic graphic_table graphicRef75417 \">table 1</a>). (See <a href=\"#H3\" class=\"local\">'Benign vesiculopustular lesions'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Benign vesiculopustular lesions of the skin include erythema toxicum neonatorum, transient neonatal pustular melanosis (<a href=\"image.htm?imageKey=PEDS%2F59397\" class=\"graphic graphic_picture graphicRef59397 \">picture 3</a>), neonatal acne, milia, miliaria (<a href=\"image.htm?imageKey=PEDS%2F55627\" class=\"graphic graphic_picture graphicRef55627 \">picture 6</a> and <a href=\"image.htm?imageKey=PEDS%2F68376\" class=\"graphic graphic_picture graphicRef68376 \">picture 7</a>), infantile acropustulosis, and sucking blisters (<a href=\"image.htm?imageKey=PEDS%2F78479\" class=\"graphic graphic_picture graphicRef78479 \">picture 8</a>). Among these conditions, therapy may be required for severe neonatal acne and infantile acropustulosis. (See <a href=\"#H3\" class=\"local\">'Benign vesiculopustular lesions'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Infants with neonatal acne (neonatal cephalic pustulosis) usually do not require treatment. We suggest that infants with mild to moderate infantile acne be treated with mild keratolytic agents, topical antibiotics, or topical retinoids (<a href=\"grade.htm?i=6\" class=\"grade\">Grade 2C</a>). Oral <a href=\"topic.htm?path=erythromycin-drug-information\" class=\"drug drug_general\">erythromycin</a> or oral <a href=\"topic.htm?path=isotretinoin-drug-information\" class=\"drug drug_general\">isotretinoin</a> may be used to treat severe, scarring infantile acne. (See <a href=\"#H7\" class=\"local\">'Infantile acne'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>We suggest that flares of infantile acropustulosis be treated with mid- to high-potency topical corticosteroids (Group 1 to 4, (<a href=\"image.htm?imageKey=DERM%2F62402\" class=\"graphic graphic_table graphicRef62402 \">table 2</a>))&nbsp;(<a href=\"grade.htm?i=6\" class=\"grade\">Grade 2C</a>). Oral <a href=\"topic.htm?path=erythromycin-drug-information\" class=\"drug drug_general\">erythromycin</a> or antihistamines are alternatives. We suggest that <a href=\"topic.htm?path=dapsone-drug-information\" class=\"drug drug_general\">dapsone</a> be reserved for severe, recalcitrant cases (<a href=\"grade.htm?i=6\" class=\"grade\">Grade 2C</a>). (See <a href=\"#H8\" class=\"local\">'Infantile acropustulosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Benign causes of color change in the neonate include cutis marmorata (<a href=\"image.htm?imageKey=PEDS%2F53396\" class=\"graphic graphic_picture graphicRef53396 \">picture 9A</a>), harlequin color change, congenital dermal melanocytosis (Mongolian spot) (<a href=\"image.htm?imageKey=PEDS%2F77805\" class=\"graphic graphic_picture graphicRef77805 \">picture 10</a>), and bronze baby syndrome. (See <a href=\"#H13\" class=\"local\">'Color changes'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Physiologic cutis marmorata resolves with warming. This distinguishes it from cutis marmorata telangiectatica congenita, which may be associated with extracutaneous manifestations. (See <a href=\"#H14\" class=\"local\">'Cutis marmorata'</a> above and <a href=\"topic.htm?path=vascular-lesions-in-the-newborn#H8\" class=\"medical medical_review\">&quot;Vascular lesions in the newborn&quot;, section on 'Cutis marmorata telangiectatica congenita'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Congenital dermal melanocytosis should always be documented when detected on examination; this will help to avoid confusion with bruises in the event that child abuse is suspected. (See <a href=\"#H16\" class=\"local\">'Congenital dermal melanocytosis (Mongolian spot)'</a> above and <a href=\"topic.htm?path=differential-diagnosis-of-suspected-child-physical-abuse#H2\" class=\"medical medical_review\">&quot;Differential diagnosis of suspected child physical abuse&quot;, section on 'Bruises'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Benign scalp lesions in newborns and young infants include seborrheic dermatitis (&quot;cradle cap&rdquo; (<a href=\"image.htm?imageKey=PEDS%2F55801\" class=\"graphic graphic_picture graphicRef55801 \">picture 11</a>)), nevus sebaceous of Jadassohn (<a href=\"image.htm?imageKey=DERM%2F89876\" class=\"graphic graphic_picture graphicRef89876 \">picture 12A</a>), halo scalp ring, and erosive pustular dermatosis of the scalp. (See <a href=\"#H18\" class=\"local\">'Scalp lesions'</a> above and <a href=\"topic.htm?path=cradle-cap-and-seborrheic-dermatitis-in-infants\" class=\"medical medical_review\">&quot;Cradle cap and seborrheic dermatitis in infants&quot;</a> and <a href=\"topic.htm?path=nevus-sebaceus-and-nevus-sebaceus-syndrome\" class=\"medical medical_review\">&quot;Nevus sebaceus and nevus sebaceus syndrome&quot;</a>.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/1\" class=\"nounderline abstract_t\">Carr JA, Hodgman JE, Freedman RI, Levan NE. Relationship between toxic erythema and infant maturity. Am J Dis Child 1966; 112:129.</a></li><li><a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/2\" class=\"nounderline abstract_t\">Treadwell PA. Dermatoses in newborns. Am Fam Physician 1997; 56:443.</a></li><li class=\"breakAll\">Paller AS, Mancini AJ. Cutaneous disorders of the newborn. In: Hurwitz Clinical Pediatric Dermatology, 5th ed, Elsevier Saunders, Philadelphia 2016. p.16.</li><li><a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/4\" class=\"nounderline abstract_t\">Berg FJ, Solomon LM. Erythema neonatorum toxicum. Arch Dis Child 1987; 62:327.</a></li><li><a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/5\" class=\"nounderline abstract_t\">Ramamurthy RS, Reveri M, Esterly NB, et al. Transient neonatal pustular melanosis. J Pediatr 1976; 88:831.</a></li><li><a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/6\" class=\"nounderline abstract_t\">Barr RJ, Globerman LM, Werber FA. Transient neonatal pustular melanosis. Int J Dermatol 1979; 18:636.</a></li><li><a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/7\" class=\"nounderline abstract_t\">Katsambas AD, Katoulis AC, Stavropoulos P. Acne neonatorum: a study of 22 cases. Int J Dermatol 1999; 38:128.</a></li><li class=\"breakAll\">Transient benign cutaneous lesions in the newborn. In: Neonatal Dermatology, 2nd ed, Eichenfield LF, Frieden IJ, Esterly NB (Eds), Saunders, Philadelphia 2008. p.90.</li><li><a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/9\" class=\"nounderline abstract_t\">Niamba P, Weill FX, Sarlangue J, et al. Is common neonatal cephalic pustulosis (neonatal acne) triggered by Malassezia sympodialis? Arch Dermatol 1998; 134:995.</a></li><li><a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/10\" class=\"nounderline abstract_t\">Bernier V, Weill FX, Hirigoyen V, et al. Skin colonization by Malassezia species in neonates: a prospective study and relationship with neonatal cephalic pustulosis. Arch Dermatol 2002; 138:215.</a></li><li><a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/11\" class=\"nounderline abstract_t\">Ayhan M, Sancak B, Karaduman A, et al. Colonization of neonate skin by Malassezia species: relationship with neonatal cephalic pustulosis. J Am Acad Dermatol 2007; 57:1012.</a></li><li class=\"breakAll\">Paller AS, Mancini AJ. Disorders of the sebaceous and sweat glands. In: Hurwitz Clinical Pediatric Dermatology, 3rd ed, Elsevier Saunders, Philadelphia 2006. p.185.</li><li><a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/13\" class=\"nounderline abstract_t\">Rapelanoro R, Mortureux P, Couprie B, et al. Neonatal Malassezia furfur pustulosis. Arch Dermatol 1996; 132:190.</a></li><li class=\"breakAll\">Hoath SB, Narendran V. The skin. In: Neonatal-Perinatal Medicine, 9th ed, Fanaroff AA,  Martin RJ, Walsh MC (Eds), Elsevier Mosby, St. Louis 2011. p.1705.</li><li><a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/15\" class=\"nounderline abstract_t\">Cunliffe WJ, Baron SE, Coulson IH. A clinical and therapeutic study of 29 patients with infantile acne. Br J Dermatol 2001; 145:463.</a></li><li><a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/16\" class=\"nounderline abstract_t\">Barnes CJ, Eichenfield LF, Lee J, Cunningham BB. A practical approach for the use of oral isotretinoin for infantile acne. Pediatr Dermatol 2005; 22:166.</a></li><li><a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/17\" class=\"nounderline abstract_t\">O'Connor NR, McLaughlin MR, Ham P. Newborn skin: Part I. Common rashes. Am Fam Physician 2008; 77:47.</a></li><li><a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/18\" class=\"nounderline abstract_t\">Humeau S, Bureau B, Litoux P, Stalder JF. Infantile acropustulosis in six immigrant children. Pediatr Dermatol 1995; 12:211.</a></li><li><a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/19\" class=\"nounderline abstract_t\">Mancini AJ, Frieden IJ, Paller AS. Infantile acropustulosis revisited: history of scabies and response to topical corticosteroids. Pediatr Dermatol 1998; 15:337.</a></li><li><a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/20\" class=\"nounderline abstract_t\">Good LM, Good TJ, High WA. Infantile acropustulosis in internationally adopted children. J Am Acad Dermatol 2011; 65:763.</a></li><li><a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/21\" class=\"nounderline abstract_t\">Jennings JL, Burrows WM. Infantile acropustulosis. J Am Acad Dermatol 1983; 9:733.</a></li><li><a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/22\" class=\"nounderline abstract_t\">Dromy R, Raz A, Metzker A. Infantile acropustulosis. Pediatr Dermatol 1991; 8:284.</a></li><li><a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/23\" class=\"nounderline abstract_t\">Van Praag MC, Van Rooij RW, Folkers E, et al. Diagnosis and treatment of pustular disorders in the neonate. Pediatr Dermatol 1997; 14:131.</a></li><li><a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/24\" class=\"nounderline abstract_t\">Vignon-Pennamen MD, Wallach D. Infantile acropustulosis. A clinicopathologic study of six cases. Arch Dermatol 1986; 122:1155.</a></li><li><a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/25\" class=\"nounderline abstract_t\">Bundino S, Zina AM, Ubertalli S. Infantile acropustulosis. Dermatologica 1982; 165:615.</a></li><li><a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/26\" class=\"nounderline abstract_t\">Kahn G, Rywlin AM. Acropustulosis of infancy. Arch Dermatol 1979; 115:831.</a></li><li><a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/27\" class=\"nounderline abstract_t\">Findlay RF, Odom RB. Infantile acropustulosis. Am J Dis Child 1983; 137:455.</a></li><li><a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/28\" class=\"nounderline abstract_t\">Feng E, Janniger CK. Miliaria. Cutis 1995; 55:213.</a></li><li><a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/29\" class=\"nounderline abstract_t\">Adam R, Schroten H. Picture of the month. Congenital sucking blisters. Arch Pediatr Adolesc Med 2007; 161:607.</a></li><li><a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/30\" class=\"nounderline abstract_t\">Levy R, Lam JM. Cutis marmorata telangiectatica congenita: a mimicker of a common disorder. CMAJ 2011; 183:E249.</a></li><li><a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/31\" class=\"nounderline abstract_t\">Cordova A. The Mongolian spot: a study of ethnic differences and a literature review. Clin Pediatr (Phila) 1981; 20:714.</a></li><li><a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/32\" class=\"nounderline abstract_t\">Jacobs AH, Walton RG. The incidence of birthmarks in the neonate. Pediatrics 1976; 58:218.</a></li><li><a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/33\" class=\"nounderline abstract_t\">Leung AK. Mongolian spots in Chinese children. Int J Dermatol 1988; 27:106.</a></li><li><a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/34\" class=\"nounderline abstract_t\">Onayemi O, Adejuyigbe EA, Torimiro SE, et al. Prevalence of Mongolian spots in Nigerian children in Ile-Ife, Nigeria. Niger J Med 2001; 10:121.</a></li><li><a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/35\" class=\"nounderline abstract_t\">Gupta D, Thappa DM. Mongolian spots--a prospective study. Pediatr Dermatol 2013; 30:683.</a></li><li><a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/36\" class=\"nounderline abstract_t\">Goldenhersh MA, Savin RC, Barnhill RL, Stenn KS. Malignant blue nevus. Case report and literature review. J Am Acad Dermatol 1988; 19:712.</a></li><li><a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/37\" class=\"nounderline abstract_t\">Patel BC, Egan CA, Lucius RW, et al. Cutaneous malignant melanoma and oculodermal melanocytosis (nevus of Ota): report of a case and review of the literature. J Am Acad Dermatol 1998; 38:862.</a></li><li><a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/38\" class=\"nounderline abstract_t\">Hanson M, Lupski JR, Hicks J, Metry D. Association of dermal melanocytosis with lysosomal storage disease: clinical features and hypotheses regarding pathogenesis. Arch Dermatol 2003; 139:916.</a></li><li><a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/39\" class=\"nounderline abstract_t\">Ashrafi MR, Shabanian R, Mohammadi M, Kavusi S. Extensive Mongolian spots: a clinical sign merits special attention. Pediatr Neurol 2006; 34:143.</a></li><li><a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/40\" class=\"nounderline abstract_t\">Hackbart BA, Arita JH, Pinho RS, et al. Mongolian spots are not always a benign sign. J Pediatr 2013; 162:1070.</a></li><li><a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/41\" class=\"nounderline abstract_t\">Kurata S, Ohara Y, Itami S, et al. Mongolian spots associated with cleft lip. Br J Plast Surg 1989; 42:625.</a></li><li class=\"breakAll\">Halamek LP, Stevenson DK. Neonatal jaundice and liver disease. In: Neonatal-Perinatal Medicine, 7th ed, Fanaroff AA, Martin RJ (Eds), Mosby, St. Louis 2002. p.1309.</li><li><a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/43\" class=\"nounderline abstract_t\">Rubaltelli FF, Da Riol R, D'Amore ES, Jori G. The bronze baby syndrome: evidence of increased tissue concentration of copper porphyrins. Acta Paediatr 1996; 85:381.</a></li><li><a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/44\" class=\"nounderline abstract_t\">Eisen DB, Michael DJ. Sebaceous lesions and their associated syndromes: part I. J Am Acad Dermatol 2009; 61:549.</a></li><li><a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/45\" class=\"nounderline abstract_t\">Tanzi EL, Hornung RL, Silverberg NB. Halo scalp ring: a case series and review of the literature. Arch Pediatr Adolesc Med 2002; 156:188.</a></li><li><a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/46\" class=\"nounderline abstract_t\">Das S. Permanent baldness following caput succedaneum. J R Coll Gen Pract 1980; 30:428.</a></li><li><a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/47\" class=\"nounderline abstract_t\">Siegel DH, Holland K, Phillips RJ, et al. Erosive pustular dermatosis of the scalp after perinatal scalp injury. Pediatr Dermatol 2006; 23:533.</a></li><li><a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/48\" class=\"nounderline abstract_t\">Patsatsi A, Kyriakou A, Sotiriadis D. Benign cephalic histiocytosis: case report and review of the literature. Pediatr Dermatol 2014; 31:547.</a></li><li><a href=\"https://www.uptodate.com/contents/benign-skin-and-scalp-lesions-in-the-newborn-and-infant/abstract/49\" class=\"nounderline abstract_t\">Polat Ekinci A, Buyukbabani N, Baykal C. Novel Clinical Observations on Benign Cephalic Histiocytosis in a Large Series. Pediatr Dermatol 2017; 34:392.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 5791 Version 24.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H25\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">SKIN LESIONS</a><ul><li><a href=\"#H3\" id=\"outline-link-H3\">Benign vesiculopustular lesions</a><ul><li><a href=\"#H4\" id=\"outline-link-H4\">- Erythema toxicum neonatorum</a></li><li><a href=\"#H5\" id=\"outline-link-H5\">- Transient neonatal pustular melanosis</a></li><li><a href=\"#H6\" id=\"outline-link-H6\">- Neonatal acne</a></li><li><a href=\"#H7\" id=\"outline-link-H7\">- Infantile acne</a></li><li><a href=\"#H8\" id=\"outline-link-H8\">- Infantile acropustulosis</a></li><li><a href=\"#H9\" id=\"outline-link-H9\">- Milia</a></li><li><a href=\"#H10\" id=\"outline-link-H10\">- Miliaria</a></li><li><a href=\"#H11\" id=\"outline-link-H11\">- Sucking blisters</a></li></ul></li><li><a href=\"#H12\" id=\"outline-link-H12\">Vascular birthmarks</a></li><li><a href=\"#H13\" id=\"outline-link-H13\">Color changes</a><ul><li><a href=\"#H14\" id=\"outline-link-H14\">- Cutis marmorata</a></li><li><a href=\"#H15\" id=\"outline-link-H15\">- Harlequin color change</a></li><li><a href=\"#H16\" id=\"outline-link-H16\">- Congenital dermal melanocytosis (Mongolian spot)</a></li><li><a href=\"#H17\" id=\"outline-link-H17\">- Bronze baby syndrome</a></li></ul></li></ul></li><li><a href=\"#H18\" id=\"outline-link-H18\">SCALP LESIONS</a><ul><li><a href=\"#H19\" id=\"outline-link-H19\">Seborrheic dermatitis</a></li><li><a href=\"#H20\" id=\"outline-link-H20\">Nevus sebaceous of Jadassohn</a></li><li><a href=\"#H21\" id=\"outline-link-H21\">Aplasia cutis congenita</a></li><li><a href=\"#H3861904392\" id=\"outline-link-H3861904392\">Caput succedaneum</a><ul><li><a href=\"#H22\" id=\"outline-link-H22\">- Halo scalp ring</a></li></ul></li><li><a href=\"#H23\" id=\"outline-link-H23\">Erosive pustular dermatosis of the scalp</a></li><li><a href=\"#H2244910472\" id=\"outline-link-H2244910472\">Benign cephalic histiocytosis</a></li></ul></li><li><a href=\"#PATIENT_INFORMATION\" id=\"outline-link-H24\">INFORMATION FOR PATIENTS</a></li><li><a href=\"#H25\" id=\"outline-link-H25\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DERM/5791|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=DERM/70785\" class=\"graphic graphic_picture\">- Erythema toxicum face</a></li><li><a href=\"image.htm?imageKey=DERM/78577\" class=\"graphic graphic_picture\">- Erythema toxicum trunk</a></li><li><a href=\"image.htm?imageKey=DERM/64567\" class=\"graphic graphic_picture\">- Transient neonatal pustular melanosis 1</a></li><li><a href=\"image.htm?imageKey=PEDS/59397\" class=\"graphic graphic_picture\">- Transient pustular melanosis</a></li><li><a href=\"image.htm?imageKey=DERM/56615\" class=\"graphic graphic_picture\">- Neonatal acne</a></li><li><a href=\"image.htm?imageKey=DERM/77411\" class=\"graphic graphic_picture\">- Acropustulosis of infancy 1</a></li><li><a href=\"image.htm?imageKey=DERM/55499\" class=\"graphic graphic_picture\">- Acropustulosis of infancy 2</a></li><li><a href=\"image.htm?imageKey=PEDS/55627\" class=\"graphic graphic_picture\">- Miliaria crystallina</a></li><li><a href=\"image.htm?imageKey=PEDS/68376\" class=\"graphic graphic_picture\">- Miliaria rubra</a></li><li><a href=\"image.htm?imageKey=PEDS/78479\" class=\"graphic graphic_picture\">- Intrauterine sucking lesion</a></li><li><a href=\"image.htm?imageKey=PEDS/53396\" class=\"graphic graphic_picture\">- Cutis marmorata</a></li><li><a href=\"image.htm?imageKey=DERM/50846\" class=\"graphic graphic_picture\">- Cutis marmorata - legs</a></li><li><a href=\"image.htm?imageKey=PEDS/77805\" class=\"graphic graphic_picture\">- Congenital dermal melanocytosis - Mongolian spots</a></li><li><a href=\"image.htm?imageKey=PEDS/55801\" class=\"graphic graphic_picture\">- Seborrheic dermatitis peds</a></li><li><a href=\"image.htm?imageKey=DERM/89876\" class=\"graphic graphic_picture\">- Nevus sebaceous</a></li><li><a href=\"image.htm?imageKey=DERM/89878\" class=\"graphic graphic_picture\">- Nevus sebaceous infant</a></li><li><a href=\"image.htm?imageKey=DERM/113955\" class=\"graphic graphic_picture\">- Benign cephalic histiocytosis 1</a></li><li><a href=\"image.htm?imageKey=DERM/113956\" class=\"graphic graphic_picture\">- Benign cephalic histiocytosis 2</a></li></ul></li><li><div id=\"DERM/5791|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=PEDS/75417\" class=\"graphic graphic_table\">- Differential diagnosis blister pustule infant</a></li><li><a href=\"image.htm?imageKey=DERM/62402\" class=\"graphic graphic_table\">- Topical corticosteroids</a></li><li><a href=\"image.htm?imageKey=DERM/59870\" class=\"graphic graphic_table\">- Immunohistochemical differential diagnosis of JXG</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=acquired-melanocytic-nevi-moles\" class=\"medical medical_review\">Acquired melanocytic nevi (moles)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=acute-palmoplantar-eczema-dyshidrotic-eczema\" class=\"medical medical_review\">Acute palmoplantar eczema (dyshidrotic eczema)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=benign-pigmented-skin-lesions-other-than-melanocytic-nevi-moles\" class=\"medical medical_review\">Benign pigmented skin lesions other than melanocytic nevi (moles)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=capillary-malformations-port-wine-stains-and-associated-syndromes\" class=\"medical medical_review\">Capillary malformations (port wine stains) and associated syndromes</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-pathologic-features-and-diagnosis-of-langerhans-cell-histiocytosis\" class=\"medical medical_review\">Clinical manifestations, pathologic features, and diagnosis of Langerhans cell histiocytosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=congenital-melanocytic-nevi\" class=\"medical medical_review\">Congenital melanocytic nevi</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cradle-cap-and-seborrheic-dermatitis-in-infants\" class=\"medical medical_review\">Cradle cap and seborrheic dermatitis in infants</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diagnosis-and-management-of-glucose-6-phosphate-dehydrogenase-deficiency\" class=\"medical medical_review\">Diagnosis and management of glucose-6-phosphate dehydrogenase deficiency</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=differential-diagnosis-of-suspected-child-physical-abuse\" class=\"medical medical_review\">Differential diagnosis of suspected child physical abuse</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=general-principles-of-dermatologic-therapy-and-topical-corticosteroid-use\" class=\"medical medical_review\">General principles of dermatologic therapy and topical corticosteroid use</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=inborn-errors-of-metabolism-classification\" class=\"medical medical_review\">Inborn errors of metabolism: Classification</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=infantile-hemangiomas-epidemiology-pathogenesis-clinical-features-and-complications\" class=\"medical medical_review\">Infantile hemangiomas: Epidemiology, pathogenesis, clinical features, and complications</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=juvenile-xanthogranuloma-jxg\" class=\"medical medical_review\">Juvenile xanthogranuloma (JXG)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=klippel-trenaunay-syndrome-clinical-manifestations-diagnosis-and-management\" class=\"medical medical_review\">Klippel-Trenaunay syndrome: Clinical manifestations, diagnosis, and management</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=mastocytosis-cutaneous-and-systemic-evaluation-and-diagnosis-in-children\" class=\"medical medical_review\">Mastocytosis (cutaneous and systemic): Evaluation and diagnosis in children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=miliaria\" class=\"medical medical_review\">Miliaria</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=neonatal-birth-injuries\" class=\"medical medical_review\">Neonatal birth injuries</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=nevus-sebaceus-and-nevus-sebaceus-syndrome\" class=\"medical medical_review\">Nevus sebaceus and nevus sebaceus syndrome</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=atopic-dermatitis-eczema-beyond-the-basics\" class=\"medical medical_patient\">Patient education: Atopic dermatitis (eczema) (Beyond the Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=heat-rash-prickly-heat-the-basics\" class=\"medical medical_basics\">Patient education: Heat rash (prickly heat) (The Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=seborrheic-dermatitis-including-dandruff-and-cradle-cap-beyond-the-basics\" class=\"medical medical_patient\">Patient education: Seborrheic dermatitis (including dandruff and cradle cap) (Beyond the Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pustular-psoriasis-pathogenesis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Pustular psoriasis: Pathogenesis, clinical manifestations, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=rapidly-involuting-congenital-hemangioma-rich-and-noninvoluting-congenital-hemangioma-nich\" class=\"medical medical_review\">Rapidly involuting congenital hemangioma (RICH) and noninvoluting congenital hemangioma (NICH)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=skin-nodules-in-newborns-and-infants\" class=\"medical medical_review\">Skin nodules in newborns and infants</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=spitzoid-melanocytic-neoplasms-spitz-nevus-and-atypical-spitz-tumors\" class=\"medical medical_review\">Spitzoid melanocytic neoplasms (Spitz nevus and atypical Spitz tumors)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=sturge-weber-syndrome\" class=\"medical medical_review\">Sturge-Weber syndrome</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=the-genodermatoses\" class=\"medical medical_review\">The genodermatoses</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-unconjugated-hyperbilirubinemia-in-term-and-late-preterm-infants\" class=\"medical medical_review\">Treatment of unconjugated hyperbilirubinemia in term and late preterm infants</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=tufted-angioma-kaposiform-hemangioendothelioma-and-the-kasabach-merritt-phenomenon\" class=\"medical medical_review\">Tufted angioma, kaposiform hemangioendothelioma, and the Kasabach-Merritt phenomenon</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=vascular-lesions-in-the-newborn\" class=\"medical medical_review\">Vascular lesions in the newborn</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant\" class=\"medical medical_review\">Vesiculopustular and bullous lesions in the newborn and infant</a></li></ul></div></div>","javascript":null}